NeoCart is now enrolling patients in a clinical study. To learn more about being a candidate, click here
Histogenics is a leading regenerative medicine company that combines cell therapy and tissue engineering technologies to develop highly innovative products for tissue repair and regeneration. The company’s flagship products focus on the treatment of active patients suffering from articular cartilage derived pain and immobility.
Histogenics has developed technology and products to reverse or prevent cartilage damage, regenerating healthy hyaline cartilage tissue. NeoCart®, autologous engineered neocartilage grown outside the body using the patient’s own cells, has been developed for repair of full thickness cartilage lesions. The VeriCart™ auto-regenerative cartilage matrix is being developed to stimulate cartilage regeneration in a simple, one-step procedure. The goal: an active lifestyle that can last all life long.
Copyright © 2013 · Histogenics